Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03977467
Title Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 Inhibitor
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors SCRI Development Innovations, LLC
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Florida Cancer Specialists - South Fort Myers Florida 33991 United States Details
Florida Cancer Specialists - North Saint Petersburg Florida 33705 United States Details
Florida Cancer Specialists - Panhandle Tallahassee Florida 32308 United States Details
Florida Cancer Specialists - East West Palm Beach Florida 33401 United States Details
MidAmerica Division, Inc., c/o Research Medical Center (HCA Midwest) Kansas City Missouri 64132 United States Details
Tennessee Oncology - Chattanooga Chattanooga Tennessee 37404 United States Details
Tennessee Oncology, PLLC Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from for the field